Success Metrics

Clinical Success Rate
85.0%

Based on 34 completed trials

Completion Rate
85%(34/40)
Active Trials
84(54%)
Results Posted
12%(4 trials)
Terminated
6(4%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

81.0%

34 of 42 finished

Non-Completion Rate

19.0%

8 ended early

Currently Active

84

trials recruiting

Total Trials

155

all time

Status Distribution
Active(102)
Completed(34)
Terminated(8)
Other(11)

Detailed Status

Recruiting76
Completed34
Not yet recruiting11
unknown9
Active, not recruiting8
Enrolling by invitation7

Development Timeline

Analytics

Development Status

Total Trials
155
Active
84
Success Rate
85.0%

Trials by Status

active_not_recruiting85%
not_yet_recruiting117%
suspended21%
terminated64%
unknown96%
withdrawn21%
recruiting7649%
enrolling_by_invitation75%
completed3422%

Recent Activity

Clinical Trials (155)

Showing 20 of 155 trialsScroll for more
NCT07645391

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

Recruiting
NCT07029256

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Recruiting
NCT06365905

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

Recruiting
NCT07636252

EX VIVO DRUG RESPONSE PROFILING AND OUTCOME PREDICTION IN LUNG ADENOCARCINOMA

Recruiting
NCT07595432

The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its Effect on Visual Performance.

Recruiting
NCT06783179

Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement

Recruiting
NCT07620457

Spectral Precise Image Study for Coronary Artery

Not Yet Recruiting
NCT06271291

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Recruiting
NCT07076147

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Recruiting
NCT07613593

INCLUDE-CKD: INCLUsive Digital carE for Chronic Kidney Disease

Not Yet Recruiting
NCT06880861

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

Recruiting
NCT07439471

Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance

Recruiting
NCT07215065

Examining Heavy Metal Exposure and Respiratory Health in Young Adult Electronic Cigarette Users

Completed
NCT06401889

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

Recruiting
NCT07594496

Prevalence and Clinical Manifestations of Cannabis Withdrawal in Hospitalized Patients With Hematological Malignancies Undergoing Bone Marrow Transplant (BMT) or Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Enrolling By Invitation
NCT06549413

18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer

Active Not Recruiting
NCT07177209

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

Active Not Recruiting
NCT07279571

GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

Not Yet Recruiting
NCT06387173

Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Active Not Recruiting
NCT07212491

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma

Enrolling By Invitation

Drug Details

Intervention Type
OTHER
Total Trials
155